Description
In recent years, the life sciences sector has faced mounting pressures from capital market volatility, regulatory scrutiny and evolving patient data standards. With a noticeable uptick in financial distress and a decline in successful bankruptcy resolutions, stakeholders are grappling with existential questions about sustainability, compliance, and trust. Bringing together finance, legal, operational and regulatory perspectives, this session will provide attendees with practical insights into how companies can manage risk, preserve value and protect trust – even under duress.
Conference